Premium Information is available for this item - Upgrade for $1 a day
6505-00-172-3438
And Hydrochlorothiazide Extended-Release Tablets Butabarbital Sodium Reserpine
6505001723438 001723438 BUTISERPAZIDE50
INC: 42605 And Hydrochlorothiazide Extended-Release Tablets Butabarbital Sodium Reserpine
January 2023
5
Marketplace 6505-00-172-3438
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-172-3438 1+ Documents (More...)
NE Related Documents ,BUTISERPAZIDE50 RQST NE Updated Every Day 6505-00-172-3438 RQST Updated Every
Day 6505-00-172-3438 RQST NE Related Documents ,BUTISERPAZIDE50 ,BUTISERPAZIDE50 RQST NE Updated Every
Restrictions 6505-00-172-3438
6505-00-172-3438 is a And Hydrochlorothiazide Extended-Release Tablets Butabarbital Sodium Reserpine that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-00-172-3438
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-172-3438
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-172-3438
- Part Number
- Manufacturer
- Status
- BUTISERPAZIDE50
- Manufacturer
- 04501 - Mcneil Lab Inc (Obsolete)
- Original Design
- Original Design
Datasheet 6505-00-172-3438
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 50.000 Milligrams Hydrochlorothiazide Active Ingredient And 0.100 Milligrams Reserpine Active Ingredient And 30.000 Milligrams Butabarbital Sodium Active Ingredient
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Special Features [FEAT]
- Color Orange;Long Action Method:Extended Release;Administration:Oral Nonchewable;Primary Container Type:A/A;
Similar Supply Items to 6505-00-172-3438
Freight Information 6505-00-172-3438
6505-00-172-3438 has freight characteristics.. 6505-00-172-3438 has a variance between NMFC and UFC when transported by rail and the description should be consulted.